These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24829396)

  • 1. A monotonic and prognostic genomic signature from fibroblasts for colorectal cancer initiation, progression, and metastasis.
    Berdiel-Acer M; Cuadras D; Díaz-Maroto NG; Sanjuan X; Serrano T; Berenguer A; Moreno V; Gonçalves-Ribeiro S; Salazar R; Villanueva A; Molleví DG
    Mol Cancer Res; 2014 Sep; 12(9):1254-66. PubMed ID: 24829396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature.
    Herrera M; Islam AB; Herrera A; Martín P; García V; Silva J; Garcia JM; Salas C; Casal I; de Herreros AG; Bonilla F; Peña C
    Clin Cancer Res; 2013 Nov; 19(21):5914-26. PubMed ID: 24052018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information.
    Berdiel-Acer M; Sanz-Pamplona R; Calon A; Cuadras D; Berenguer A; Sanjuan X; Paules MJ; Salazar R; Moreno V; Batlle E; Villanueva A; Molleví DG
    Mol Oncol; 2014 Oct; 8(7):1290-305. PubMed ID: 24839936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis: nonresistant cells die by nonapoptotic cell death.
    Berdiel-Acer M; Bohem ME; López-Doriga A; Vidal A; Salazar R; Martínez-Iniesta M; Santos C; Sanjuan X; Villanueva A; Molleví DG
    Neoplasia; 2011 Oct; 13(10):931-46. PubMed ID: 22028619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular signature for the prediction of recurrence in colorectal cancer.
    Wang L; Shen X; Wang Z; Xiao X; Wei P; Wang Q; Ren F; Wang Y; Liu Z; Sheng W; Huang W; Zhou X; Du X
    Mol Cancer; 2015 Feb; 14(1):22. PubMed ID: 25645394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.
    Kopetz S; Tabernero J; Rosenberg R; Jiang ZQ; Moreno V; Bachleitner-Hofmann T; Lanza G; Stork-Sloots L; Maru D; Simon I; Capellà G; Salazar R
    Oncologist; 2015 Feb; 20(2):127-33. PubMed ID: 25561511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of patients for hepatic surgery of colorectal cancer liver metastasis based on genomic aberrations.
    Bruin SC; de Ronde JJ; Wiering B; Braaf LM; de Wilt JH; Vincent AD; van Velthuysen ML; Ruers TJ; Wessels LF; van't Veer LJ
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S560-9. PubMed ID: 23783809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival.
    Torres S; Garcia-Palmero I; Herrera M; Bartolomé RA; Peña C; Fernandez-Aceñero MJ; Padilla G; Peláez-García A; Lopez-Lucendo M; Rodriguez-Merlo R; García de Herreros A; Bonilla F; Casal JI
    Clin Cancer Res; 2015 Nov; 21(21):4892-902. PubMed ID: 26206869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer.
    Berdiel-Acer M; Berenguer A; Sanz-Pamplona R; Cuadras D; Sanjuan X; Paules MJ; Santos C; Salazar R; Moreno V; Capella G; Villanueva A; Molleví DG
    Oncotarget; 2014 Aug; 5(15):6437-52. PubMed ID: 25115384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal contribution to the colorectal cancer transcriptome.
    Isella C; Terrasi A; Bellomo SE; Petti C; Galatola G; Muratore A; Mellano A; Senetta R; Cassenti A; Sonetto C; Inghirami G; Trusolino L; Fekete Z; De Ridder M; Cassoni P; Storme G; Bertotti A; Medico E
    Nat Genet; 2015 Apr; 47(4):312-9. PubMed ID: 25706627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
    Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
    Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
    Zheng H; Liu H; Ge Y; Wang X
    Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
    Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ
    Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients.
    Sveen A; Ågesen TH; Nesbakken A; Meling GI; Rognum TO; Liestøl K; Skotheim RI; Lothe RA
    Clin Cancer Res; 2012 Nov; 18(21):6001-10. PubMed ID: 22991413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic regulation and potentially therapeutic application of cancer-associated fibroblasts in oral cancer.
    Wang J; Min A; Gao S; Tang Z
    J Oral Pathol Med; 2014 May; 43(5):323-34. PubMed ID: 23782231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of cancer-associated fibroblasts in human cancer.
    Paulsson J; Micke P
    Semin Cancer Biol; 2014 Apr; 25():61-8. PubMed ID: 24560651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
    Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
    J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.